8.5368
Viemed Healthcare Inc stock is traded at $8.5368, with a volume of 115.81K.
It is down -0.28% in the last 24 hours and down -28.30% over the past month.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
See More
Previous Close:
$8.57
Open:
$8.61
24h Volume:
115.81K
Relative Volume:
0.34
Market Cap:
$324.51M
Revenue:
$286.57M
Net Income/Loss:
$15.38M
P/E Ratio:
22.73
EPS:
0.3756
Net Cash Flow:
$25.92M
1W Performance:
-7.10%
1M Performance:
-28.30%
6M Performance:
+3.72%
1Y Performance:
+21.23%
Viemed Healthcare Inc Stock (VMD) Company Profile
Name
Viemed Healthcare Inc
Sector
Industry
Phone
337.504.3802
Address
625 E. KALISTE SALOOM RD., LAFAYETTE
Compare VMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VMD
Viemed Healthcare Inc
|
8.52 | 340.51M | 286.57M | 15.38M | 25.92M | 0.3756 |
|
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.00 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Viemed Healthcare Inc Stock (VMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-21 | Initiated | RBC Capital Mkts | Outperform |
Viemed Healthcare Inc Stock (VMD) Latest News
Tocqueville Asset Management L.P. Purchases New Shares in Viemed Healthcare, Inc. $VMD - MarketBeat
Viemed (VMD) Latest Quarter: The Available Earnings Metric Delivers a Miss for the Current Session; Shares Move Lower 4.14% in the Available RecordEPS Guidance Update - Vinanet
Viemed Healthcare Announces New Share Repurchase Program of Up to 5% of Shares Outstanding - Minichart
Viemed Healthcare Updates Investor Deck, Highlights Growth Strategy - TipRanks
VieMed Healthcare posts investor presentation detailing record 2025 results and 2026 guidance - TradingView
Viemed Healthcare (VMD) maps 2026 growth after 21% revenue jump - Stock Titan
Viemed (VMD) Earnings Snapshot: The Bottom-Line Figure Trails Its Comparison in the Reported Period; Trading Response: Shares Close 3.02% Lower in the Latest ReadingRevenue Guidance Update - Vinanet
Viemed Healthcare (VMD) director settles awards, sells 4.2K shares - Stock Titan
Viemed Healthcare (NASDAQ: VMD) grants new RSUs and phantom units to director - Stock Titan
Viemed Healthcare (NASDAQ: VMD) director granted 12,174 RSUs - Stock Titan
209,066 Shares in Viemed Healthcare, Inc. $VMD Acquired by Rice Hall James & Associates LLC - MarketBeat
Viemed Healthcare Inc (NASDAQ: VMD) Share Price, VMD Stock News, VMD Share Price & Updates - Kalkine
GSA Capital Partners LLP Invests $1.46 Million in Viemed Healthcare, Inc. $VMD - MarketBeat
Viemed Healthcare (NASDAQ:VMD) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
VMD Q2 2026 Earnings: EPS Misses Consensus by 42% as Bottom-Line Pressures MountPre-Announcement Alert - Vinanet
(VMD) Risk Channels and Responsive Allocation - Stock Traders Daily
VMD Q2 2026 Earnings: EPS Falls Short of Expectations Amid Operational UncertaintyEarnings Surprise Report - Vinanet
VMD Q2 2026 Earnings: EPS Misses Expectations by 42% as Stock DeclinesCFO Commentary Report - Vinanet
Viemed (VMD) Q2 2026 Earnings Call Transcript - The Globe and Mail
Viemed Healthcare (VMD) Drops 3.75% to $9.37 — Key Support at $8.9 in FocusDelta Hedging - dars.gov.et
Why Viemed Healthcare's (NASDAQ:VMD) Earnings Are Better Than They Seem - simplywall.st
Viemed Healthcare (VMD) Slips 4.2% as Shares Test Key Support ZoneShakeout Pattern - Vinanet
Viemed Healthcare (NASDAQ:VMD) Stock Rating Lowered by Freedom Capital - MarketBeat
ResMed: Fiscal Q4 Earnings Snapshot - AOL.com
VMD Downgraded by Freedom Broker -- Rating Changed to Hold - GuruFocus
Viemed Healthcare | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Freedom Capital Markets Initiates Viemed Healthcare(VMD.US) With Hold Rating, Announces Target Price $11 - Moomoo
Earnings Preview: VMD to Report Financial Results Post-market on August 04 - Moomoo
Viemed Healthcare (VMD) Stock Price Sinks As Margin Pressure Clouds Growth - Sahm
Viemed Healthcare Q2 Earnings Call Highlights - sharewise.com
Viemed Healthcare Inc (VMD) (Q2 2026) Earnings Call Highlights: - GuruFocus
Viemed Healthcare Inc (VMD) (Q2 2026) Earnings Call Highlights: Record Revenue and Patient ... - Yahoo! Finance Canada
Viemed Q2 2026 slides show record revenue amid margin pressure By Investing.com - Investing.com Canada
Viemed Healthcare, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:VMD) 2026-08-04 - Seeking Alpha
Viemed Healthcare Misses Q2 2026 EPS by 41.7%, Surging Revenue - AlphaStreet
Earnings call transcript: Viemed Healthcare Q2 2026 profit miss sends shares down 17% - Investing.com Nigeria
Viemed Q2 2026 slides show record revenue amid margin pressure - Investing.com
Viemed Healthcare, Inc. Updates Earnings Guidance for the Full Year Ending December 31, 2026 - marketscreener.com
VMD: Record revenue and patient growth led to raised full-year guidance and continued expansion - tradingview.com
Q2 2026 Viemed Healthcare Inc Earnings Call Transcript - GuruFocus
Viemed Healthcare Down Over 17%, On Track for Largest Percent Decrease Since January 2019 -- Data Talk - Bitget
Viemed Healthcare Reports Q2 2026 Financial Results: Steady Revenue Growth and Strong Net Income - Minichart
Viemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Viemed Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
VMD: Record revenue and patient growth drive raised 2026 guidance and strong cash generation - TradingView
Tranche Update on Viemed Healthcare, Inc.'s Equity Buyback Plan announced on March 4, 2026. - marketscreener.com
Viemed Healthcare Q2 2026 Financial Results | NASDAQ: VMD - ACCESS Newswire
Viemed Healthcare Announces Second Quarter 2026 Financial Results - The Globe and Mail
Lazard Asset Management LLC Increases Position in Viemed Healthcare, Inc. $VMD - MarketBeat
(VMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Viemed Healthcare Q2 2026 Earnings Call Transcript - MarketBeat
Viemed Healthcare Inc Stock (VMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Viemed Healthcare Inc Stock (VMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Frazier William | Chief Medical Officer |
Jun 25 '26 |
Sale |
11.72 |
10,000 |
117,200 |
73,214 |
| Smokoff Timothy | Director |
Jun 24 '26 |
Sale |
11.50 |
20,000 |
229,967 |
75,518 |
| Moore Michael | President |
Mar 20 '26 |
Sale |
8.77 |
65,000 |
570,050 |
1,585,812 |
| Moore Michael | President |
Mar 19 '26 |
Sale |
9.21 |
40,232 |
370,537 |
1,650,812 |
| Moore Michael | President |
Mar 18 '26 |
Sale |
9.42 |
31,570 |
297,389 |
1,691,044 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):